share_log

HC Wainwright & Co. Maintains Buy on Cabaletta Bio, Raises Price Target to $25

HC Wainwright & Co. Maintains Buy on Cabaletta Bio, Raises Price Target to $25

HC Wainwright & Co.维持对Cabaletta Bio的买入,将目标价提高至25美元
Benzinga ·  2023/11/10 07:51

HC Wainwright & Co. analyst Douglas Tsao maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target from $17 to $25.

HC Wainwright & Co. 分析师曹道格拉斯维持Cabaletta Bio(纳斯达克股票代码:CABA)的买入,并将目标股价从17美元上调至25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发